About the Cancer Center
The Children's Mercy Cancer Center provides comprehensive pediatric cancer care to nearly 2,000 children each year. Our commitment to clinical research and innovation has helped us earn recognition as one of the top cancer programs in the nation by U.S. News and World Report.
Cancer Center Staff
Our unique case management system pairs each of our more than 20 board-certified physicians with an advanced practice nurse or physician assistant and a social worker to provide comprehensive pediatric care to our patients and families. Our staff provides 24/7 pediatric hematology and pediatric oncology coverage within the hospital.
Our team is currently conducting research on a broad range of topics including neuroblastoma, stem cell function in treating sickle cell disease and Chrohn's disease, new treatment for fanconi anemia and T-cell acute lymphoblasatic leukemia. Other current research projects include:
The Center for Pediatric Genomic Medicine and the Experimental Therapeutics in Cancer program are conducting breakthrough research to better understand the genetic causes of pediatric cancer.
Bridging the Gap
The goals of this project are to assess health care provider’s knowledge of the unique needs of childhood cancer survivors, develop a face-to-face meeting and web-based educational series to improve that knowledge, and evaluate performance improvement strategies among selected clinical sites.
Parent Satisfaction in Outpatient Bone Marrow Transplantation Clinic
This two-part study will help us better understand parents' needs and concerns during the outpatient bone marrow transplantation experience.
Effects of Intrathecal Methotrexate
We're currently studying the effects of intrathecal methotrexate on folate metabolism in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
Elongation Factor Protein
This study will broaden our understanding of how proteins and genes interact inside leukemia cells. We think that this will help us better understand how leukemia develops.
Pediatric Formulation of Chemotherapy
This study will help us create a child-friendly version of chemotherapy drugs that are as effective as the originally available commercial version.
Immunotherapy for GD2 Positive Tumors
Our researchers are looking to discover how joining the anti-GD2 antibody to T-cells can provide protection from viruses and kill cancer cells.